Filing Details

Accession Number:
0000899243-23-005877
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-22 18:39:23
Reporting Period:
2023-02-17
Accepted Time:
2023-02-22 18:39:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785173 89Bio Inc. ETNB Pharmaceutical Preparations (2834) 831114349
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1792018 Ryan Martins C/O 89Bio, Inc.
142 Sansome Street, 2Nd Floor
San Francisco CA 94104
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-17 1,750 $13.97 61,118 No 4 F Direct
Common Stock Disposition 2023-02-21 2,540 $13.89 58,578 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 4,290 restricted stock units on February 17, 2023.
  2. This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $13.72 to $14.32. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.